 Bennett Davenport
Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chikungunya virus | 13 | 2026 | 81 | 2.470 |
Why?
| | CD8-Positive T-Lymphocytes | 11 | 2025 | 919 | 2.260 |
Why?
| | Chikungunya Fever | 12 | 2026 | 82 | 2.050 |
Why?
| | Immunologic Memory | 6 | 2025 | 368 | 1.820 |
Why?
| | Lymphocytic choriomeningitis virus | 5 | 2025 | 36 | 1.510 |
Why?
| | Lymph Nodes | 6 | 2025 | 503 | 0.970 |
Why?
| | Lymphocytic Choriomeningitis | 3 | 2025 | 25 | 0.880 |
Why?
| | Chemokines | 4 | 2020 | 217 | 0.830 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 174 | 0.810 |
Why?
| | Joints | 2 | 2026 | 106 | 0.800 |
Why?
| | Viral Envelope Proteins | 4 | 2025 | 98 | 0.730 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2026 | 1140 | 0.690 |
Why?
| | Arenaviridae Infections | 2 | 2019 | 17 | 0.640 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.620 |
Why?
| | Alphavirus Infections | 4 | 2021 | 45 | 0.600 |
Why?
| | Leishmania major | 1 | 2018 | 8 | 0.570 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 14 | 0.560 |
Why?
| | Aging | 2 | 2019 | 1969 | 0.550 |
Why?
| | Mental Recall | 1 | 2019 | 222 | 0.530 |
Why?
| | Mice | 27 | 2026 | 18329 | 0.510 |
Why?
| | Virulence Factors | 1 | 2018 | 174 | 0.500 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 308 | 0.490 |
Why?
| | Macrophages | 3 | 2026 | 1507 | 0.480 |
Why?
| | Cytokines | 3 | 2020 | 2067 | 0.460 |
Why?
| | Animals | 36 | 2026 | 38030 | 0.460 |
Why?
| | Mice, Inbred C57BL | 16 | 2026 | 5983 | 0.440 |
Why?
| | Viremia | 3 | 2025 | 160 | 0.410 |
Why?
| | Phagocytes | 2 | 2025 | 80 | 0.400 |
Why?
| | Antiviral Agents | 3 | 2025 | 769 | 0.350 |
Why?
| | Mice, Knockout | 8 | 2025 | 3124 | 0.340 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 26 | 0.320 |
Why?
| | Antibodies, Viral | 3 | 2025 | 674 | 0.310 |
Why?
| | Adaptive Immunity | 3 | 2020 | 167 | 0.300 |
Why?
| | Receptors, Immunologic | 2 | 2021 | 208 | 0.300 |
Why?
| | Mice, Inbred BALB C | 3 | 2020 | 1261 | 0.280 |
Why?
| | Disease Models, Animal | 8 | 2026 | 4560 | 0.270 |
Why?
| | Peromyscus | 2 | 2004 | 5 | 0.270 |
Why?
| | Antigen Presentation | 2 | 2025 | 207 | 0.250 |
Why?
| | Mice, Transgenic | 7 | 2025 | 2188 | 0.250 |
Why?
| | Killer Cells, Natural | 3 | 2025 | 480 | 0.230 |
Why?
| | Insulin-Secreting Cells | 2 | 2022 | 392 | 0.230 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2025 | 40 | 0.230 |
Why?
| | Encephalomyelitis, Equine | 1 | 2025 | 3 | 0.230 |
Why?
| | Encephalitis Virus, Eastern Equine | 1 | 2025 | 5 | 0.230 |
Why?
| | Cysteine Proteases | 1 | 2025 | 8 | 0.220 |
Why?
| | Antibodies, Neutralizing | 2 | 2025 | 340 | 0.220 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2025 | 49 | 0.220 |
Why?
| | Molecular Probes | 1 | 2025 | 33 | 0.220 |
Why?
| | Clodronic Acid | 1 | 2025 | 19 | 0.220 |
Why?
| | Orthomyxoviridae Infections | 1 | 2025 | 71 | 0.210 |
Why?
| | Immune Evasion | 1 | 2025 | 61 | 0.210 |
Why?
| | Immunization | 3 | 2024 | 375 | 0.210 |
Why?
| | Virus Replication | 3 | 2026 | 521 | 0.210 |
Why?
| | Endothelial Cells | 3 | 2025 | 874 | 0.210 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 334 | 0.200 |
Why?
| | Antigens | 1 | 2025 | 348 | 0.200 |
Why?
| | Virulence | 3 | 2021 | 278 | 0.200 |
Why?
| | Ross River virus | 2 | 2021 | 23 | 0.200 |
Why?
| | NADPH Oxidases | 1 | 2024 | 122 | 0.200 |
Why?
| | Kupffer Cells | 2 | 2021 | 52 | 0.190 |
Why?
| | Methionine | 1 | 2024 | 161 | 0.190 |
Why?
| | Lectins, C-Type | 2 | 2020 | 59 | 0.190 |
Why?
| | Liposomes | 1 | 2025 | 262 | 0.190 |
Why?
| | Interferon Type I | 2 | 2021 | 147 | 0.180 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 78 | 0.180 |
Why?
| | Salmonella | 1 | 2022 | 47 | 0.180 |
Why?
| | Dendritic Cells | 2 | 2025 | 499 | 0.170 |
Why?
| | Viral Vaccines | 1 | 2022 | 107 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 425 | 0.160 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 7 | 0.160 |
Why?
| | Cell Survival | 2 | 2025 | 1100 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2597 | 0.160 |
Why?
| | Transcriptional Activation | 1 | 2022 | 372 | 0.160 |
Why?
| | Proteome | 1 | 2025 | 514 | 0.160 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.150 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 23 | 0.150 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 337 | 0.150 |
Why?
| | Adoptive Transfer | 1 | 2020 | 200 | 0.150 |
Why?
| | Lymphocyte Activation | 4 | 2025 | 1132 | 0.150 |
Why?
| | Arthritis | 1 | 2020 | 96 | 0.150 |
Why?
| | Parasite Load | 1 | 2018 | 10 | 0.140 |
Why?
| | Leishmania donovani | 1 | 2018 | 12 | 0.140 |
Why?
| | Chronic Disease | 2 | 2026 | 1808 | 0.140 |
Why?
| | Lung | 2 | 2025 | 4106 | 0.140 |
Why?
| | Gene Deletion | 2 | 2018 | 391 | 0.140 |
Why?
| | Antigens, Viral | 1 | 2018 | 182 | 0.130 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2019 | 749 | 0.130 |
Why?
| | Acute Disease | 1 | 2020 | 1036 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 101 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2018 | 4148 | 0.130 |
Why?
| | Nuclear Proteins | 2 | 2022 | 740 | 0.130 |
Why?
| | Glucose | 2 | 2022 | 1048 | 0.120 |
Why?
| | Oxidative Stress | 2 | 2022 | 1356 | 0.120 |
Why?
| | TRPM Cation Channels | 2 | 2008 | 73 | 0.120 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 418 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2022 | 1164 | 0.110 |
Why?
| | Bacterial Proteins | 1 | 2022 | 967 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 673 | 0.110 |
Why?
| | Monocytes | 1 | 2017 | 539 | 0.110 |
Why?
| | RNA, Viral | 3 | 2026 | 692 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 959 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2017 | 305 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2382 | 0.090 |
Why?
| | Vaccination | 1 | 2021 | 1426 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1505 | 0.090 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2013 | 177 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2664 | 0.090 |
Why?
| | Neutrophils | 1 | 2017 | 1124 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 686 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2017 | 1131 | 0.080 |
Why?
| | Male | 6 | 2020 | 72842 | 0.080 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 362 | 0.080 |
Why?
| | Epitopes | 2 | 2025 | 473 | 0.080 |
Why?
| | Transcription Factors | 1 | 2018 | 1734 | 0.080 |
Why?
| | Female | 7 | 2026 | 78844 | 0.080 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1996 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1789 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2025 | 2507 | 0.070 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 27 | 0.070 |
Why?
| | Humans | 19 | 2025 | 145474 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2008 | 105 | 0.070 |
Why?
| | Parkinsonian Disorders | 1 | 2008 | 43 | 0.070 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2008 | 95 | 0.070 |
Why?
| | Viral Load | 2 | 2021 | 526 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 2004 | 538 | 0.060 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 161 | 0.060 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 1 | 2025 | 21 | 0.060 |
Why?
| | Transcriptome | 2 | 2025 | 1038 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 693 | 0.050 |
Why?
| | Orthobunyavirus | 1 | 2025 | 8 | 0.050 |
Why?
| | Bunyaviridae Infections | 1 | 2025 | 15 | 0.050 |
Why?
| | Hemocyanins | 1 | 2004 | 61 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2025 | 78 | 0.050 |
Why?
| | Immune Sera | 1 | 2004 | 77 | 0.050 |
Why?
| | Mutation | 3 | 2025 | 4075 | 0.050 |
Why?
| | Sulfones | 1 | 2025 | 127 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 159 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 65 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2004 | 132 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2025 | 2046 | 0.050 |
Why?
| | Insulin | 2 | 2018 | 2512 | 0.050 |
Why?
| | B-Lymphocytes | 2 | 2019 | 870 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2004 | 440 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 206 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2004 | 321 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 364 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2023 | 247 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 688 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 188 | 0.040 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 62 | 0.040 |
Why?
| | Interferon Regulatory Factors | 1 | 2022 | 44 | 0.040 |
Why?
| | Binding Sites | 1 | 2025 | 1310 | 0.040 |
Why?
| | Phenylalanine | 1 | 2022 | 69 | 0.040 |
Why?
| | HeLa Cells | 1 | 2023 | 632 | 0.040 |
Why?
| | Alphavirus | 1 | 2021 | 22 | 0.040 |
Why?
| | Feedback | 1 | 2022 | 180 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 129 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 302 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 776 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3542 | 0.040 |
Why?
| | Amino Acids | 1 | 2025 | 519 | 0.040 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 63 | 0.040 |
Why?
| | Protein Domains | 1 | 2022 | 311 | 0.040 |
Why?
| | Viral Tropism | 1 | 2019 | 36 | 0.040 |
Why?
| | Cricetinae | 1 | 2020 | 305 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 611 | 0.040 |
Why?
| | Venules | 1 | 2018 | 14 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 13 | 0.040 |
Why?
| | Organelle Biogenesis | 1 | 2018 | 14 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1767 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 361 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2022 | 419 | 0.030 |
Why?
| | Conserved Sequence | 2 | 2009 | 244 | 0.030 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 6 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2017 | 16 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 82 | 0.030 |
Why?
| | Ovalbumin | 1 | 2018 | 194 | 0.030 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 16 | 0.030 |
Why?
| | Mitochondrial Dynamics | 1 | 2018 | 40 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2017 | 45 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 121 | 0.030 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 39 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 335 | 0.030 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 65 | 0.030 |
Why?
| | RNA Transport | 1 | 2017 | 27 | 0.030 |
Why?
| | Spleen | 1 | 2019 | 508 | 0.030 |
Why?
| | Protein Subunits | 1 | 2018 | 229 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 88 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2018 | 186 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 305 | 0.030 |
Why?
| | Cadaver | 1 | 2018 | 311 | 0.030 |
Why?
| | Magnesium | 2 | 2008 | 156 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 40 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 333 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 49 | 0.030 |
Why?
| | RNA Interference | 1 | 2018 | 475 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 224 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 328 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 666 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2018 | 718 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2021 | 835 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 226 | 0.030 |
Why?
| | Cell Membrane | 2 | 2008 | 707 | 0.020 |
Why?
| | Thymus Gland | 1 | 2014 | 312 | 0.020 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 2129 | 0.020 |
Why?
| | B7-2 Antigen | 1 | 2011 | 27 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2883 | 0.020 |
Why?
| | CD28 Antigens | 1 | 2011 | 59 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2011 | 55 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3922 | 0.020 |
Why?
| | Pneumonia | 1 | 2017 | 636 | 0.020 |
Why?
| | Nanoparticles | 1 | 2017 | 517 | 0.020 |
Why?
| | Viruses | 1 | 2013 | 165 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5584 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2009 | 45 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1162 | 0.020 |
Why?
| | Amino Acids, Diamino | 1 | 2008 | 1 | 0.020 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2008 | 5 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 61 | 0.020 |
Why?
| | Guam | 1 | 2008 | 17 | 0.020 |
Why?
| | Hybridomas | 1 | 2009 | 233 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2008 | 94 | 0.020 |
Why?
| | Proline | 1 | 2008 | 82 | 0.020 |
Why?
| | Leucine | 1 | 2008 | 116 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5216 | 0.020 |
Why?
| | Bacteria | 1 | 2013 | 765 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 613 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 335 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2008 | 245 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.010 |
Why?
| | Autoantigens | 1 | 2009 | 427 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 72 | 0.010 |
Why?
| | Temperature | 1 | 2008 | 633 | 0.010 |
Why?
| | Evolution, Molecular | 1 | 2008 | 492 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 756 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 273 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1598 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 362 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 2238 | 0.010 |
Why?
| | Calcium | 1 | 2008 | 1190 | 0.010 |
Why?
| | Interleukins | 1 | 2004 | 248 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 977 | 0.010 |
Why?
| | Homeostasis | 1 | 2005 | 642 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1707 | 0.010 |
Why?
| | Cell Line | 1 | 2005 | 2823 | 0.010 |
Why?
|
|
Davenport's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|